Hostname: page-component-78c5997874-t5tsf Total loading time: 0 Render date: 2024-11-10T17:13:56.319Z Has data issue: false hasContentIssue false
  • English
  • Français

La naltrexona como tratamiento del comportamiento autolesivo: un informe clínico

Published online by Cambridge University Press:  12 May 2020

H. Griengl  and
K. Dantendorfer
H. Griengl
Affiliation:
Departamento de Psiquiatría, División de Psiquiatría Social, Hospital Universitario, Viena, Austria
K. Dantendorfer
Affiliation:
Departamento de Psiquiatría, División de Psiquiatría Social, Hospital Universitario, Viena, Austria

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Carta al director
Information
European Psychiatry (Ed. Española) , Volume 8 , Issue 5 , June 2001 , pp. 332 - 334
Copyright
Copyright © European Psychiatric Association 2001

References

Bibliografía

Buzan, RD, Dubovsky, SL, Treadway, JT, Thomas, MOpiate antagonists for recurrent self-njurious behavior in three mentally retarded adults. Psychiatr Serv 1995; 46: 511–2.Google ScholarPubMed
Casner, JA, Weinheimer, B, Gualtieri, CTNaltrexone and self-injurious behavior: a retrospective population study. J Clin Psychopharmacol 1996; 16: 389–94.CrossRefGoogle ScholarPubMed
Gehring, A, Blaser, AMinnesota Multiphasic Personality Inventory-Deutsche Kurzform für die Handaueswertung. Bern: Huber; 1982.Google Scholar
Kars, H, Broekema, W, van, Glaudemans IG, Verhoeven, WM, van, Ree JMNaltrexone attenuates self-injurious behavior in mentally retarded subjects. Biol Psychiatry 1990; 27: 741–6.CrossRefGoogle ScholarPubMed
Markowitz, PIEffects of fluoxetine on self-injurious behavior in the developmental^ disabled: a preliminary study. J Clin Psychopharmacol 1992; 12: 27–31.CrossRefGoogle ScholarPubMed
McGee, MDCessation of self-mutilation in a patient with borderline personality disorder treated with naltrexone. J Clin Psychiatry 1997; 58: 32–3.CrossRefGoogle Scholar
New, AS, Tresman, RL, Mitropoulou, V, Benishay, DS, Coccaro, E, Silverman, Jet al. Serotonergic function and self-injurious behavior in personality disorder patients. Psychiatry Res 1997; 69: 17–26.CrossRefGoogle ScholarPubMed
Pies, RW, Popli, APSelf-injurious behaviour: pathophysiology and implications for treatment. J Clin Psychiatry 1995; 56: 580–8.Google ScholarPubMed
Roth, AS, Ostroff, RB, Hoffman, RENaltrexone as a treatment for repetitive self-injurious behavior: an open-label trial. J Clin Psychiatry 1996; 57: 233–7.Google Scholar
Sonne, S, Rubey, RNaltrexone treatment of self-injurious thoughts and behaviors. J Nerv Ment Dis 1996; 184: 192–5.Google ScholarPubMed
Winchel, M, Stanley, MSelf-injurious behavior: a review of the behavior and biology of self-mutilation. Am J Psychiatry 1991; 148: 306–17.Google ScholarPubMed